Day: March 28, 2026

Protagonist Announces Presentation of One-Year Phase 3 Data for ICOTYDE(TM) in Moderate-to-Severe Plaque Psoriasis at the 2026 American Academy of Dermatology (AAD) Annual Meeting

New SPRAVATO® (esketamine nasal spray) data support robust effectiveness and show durable effect for treatment resistant depression in a real-world setting

Johnson & Johnson presents findings from the largest European real-world dataset for esketamine nasal spray (NS) which confirm its effectiveness...

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World Congress of Nephrology

Vivoryon Therapeutics N.V. Provides Update on Growing Body of Evidence Validating Glutaminyl Cyclases as Promising Targets in DKD at World...

TheraWolf PainBalm and NeuroBalm Claims Evaluated: What Buyers Are Overlooking About Topical Relief Formulas, Ingredients, and Pricing in 2026

A 2026 consumer overview of TheraWolf PainBalm and NeuroBalm ingredient disclosures, topical magnesium balm research context, botanical pain relief cream...

error: Content is protected !!